New drug HOPO 14-1 passes first safety check in healthy volunteers
NCT ID NCT05628961
First seen Nov 16, 2025 · Last updated May 07, 2026 · Updated 24 times
Summary
This study tested a single dose of an experimental drug called HOPO 14-1 in 42 healthy adults to see if it is safe and how the body processes it. Participants took one capsule and were monitored for side effects and drug levels in the blood. The goal was to find a safe dose up to 7500 mg for future studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOXICITY;CHEMICAL are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
SRI International Clinical Trials Unit
Plymouth, Michigan, 48170, United States
Conditions
Explore the condition pages connected to this study.